Litcius/Paper detail

PAI-1-driven SFRP2high cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy

Yan-Pei Zhang, Ze-Qin Guo, Xiao-Ting Cai, Zi-Xuan Rong, Yuan Fang, Jiaqi Chen, Kexin Zhuang, Min Ruan, Si-Cong Ma, Le-Yi Lin, Duan-Duan Han, Yang-Si Li, Yuanyuan Wang, Jian Wang, Chuanhui Cao, Xin-Ran Tang, Qiankun Xie, Yue Chen, Yan Lin, Jia-Le Tan, Zihang Yu, Zhong Wu, Wei Wei, Dayong Zheng, Yu-Jie Zeng, Yu Ruan, Zipeng Xu, Jianying Gu, Lushan Xiao, Li Liu, Jian Guan, Xue Bai, Di Wu, Zhong‐Yi Dong

2025Cancer Cell32 citationsDOI

Topics & Concepts

RadioimmunotherapyCancer researchCancerBiologyMedicineImmunologyInternal medicineAntibodyMonoclonal antibodyCancer Immunotherapy and BiomarkersCancer Cells and MetastasisRadiopharmaceutical Chemistry and Applications
PAI-1-driven SFRP2high cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy | Litcius